Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Mounjaro and Zepbound no longer in shortage

by
October 3, 2024
in Health Care
0
Mounjaro and Zepbound no longer in shortage

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been resolved.

Tirzepatide, the active ingredient in the diabetes and obesity medications Mounjaro and Zepbound, was declared in shortage in December 2022. The shortage has been attributed to increased demand as interest in GLP-1 medications has soared.

The Food and Drug Administration (FDA) confirmed in a statement Wednesday that the shortage is now considered to be resolved.

“FDA confirmed with the drug’s manufacturer that their stated product availability and manufacturing capacity can meet the present and projected national demand,” the agency said in a statement. “Patients and prescribers may still see intermittent localized supply disruptions as the products move through the supply chain from the manufacturer and distributors to local pharmacies.”

The drug’s shortage status has allowed for compounded versions, which drug manufacturers have derisively referred to as “copycat” versions, to be sold through clinics and telehealth platforms.

These compounded versions have proliferated online, promising consumers the same active ingredient for a fraction of the cost. While compounding pharmacies are FDA-regulated, the products they sell are not and obesity specialists have raised concerns about the widespread availability of these drugs.

In its announcement of the shortage ending, the FDA offered some clarification regarding compounded GLP-1 drugs.

“Compounded drugs are not approved by FDA. FDA-approved drugs go through FDA’s rigorous review for safety, effectiveness, and quality as part of the premarket approval process,” said the agency.

There are two types of compounding pharmacies: 503A and 503B. Telehealth platforms use 503B compounding pharmacies to source their compounded GLP-1s.

The FDA reiterated Wednesday that under the Federal Food, Drug and Cosmetic Act, compounded drugs sold by 503B pharmacies “may not be identical or nearly identical to an FDA-approved drug unless the approved drug is on FDA’s drug shortage list.”

With tirzepatide no longer in shortage, the ability of online companies to sell their compounded versions now falls under question. One such platform, Eden, is still selling its compounded tirzepatide as of Wednesday evening. The Hill has reached out to the company for comment.

Eli Lilly, the manufacturer of tirzepatide, has sued medspas and pharmacies selling compounded versions. The company has previously said it was “deeply concerned about the proliferation of counterfeit, fake, and other unapproved and untested incretin knockoffs.”

The Hill has reached out to Eli Lilly for comment.

Previous Post

Amber Thurman’s family thanks Walz, condemns GOP on abortion

Next Post

Trump, Vance try out new tone on abortion 

Next Post
Trump, Vance try out new tone on abortion 

Trump, Vance try out new tone on abortion 

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    Trump administration halts government hunger report

    Trump administration halts government hunger report

    September 22, 2025
    Former acting CDC director says he ‘can’t look to’ center for trusted info 

    Former acting CDC director says he ‘can’t look to’ center for trusted info 

    September 21, 2025
    Schumer, Jeffries demand meeting with Trump to avoid government shutdown

    Schumer, Jeffries demand meeting with Trump to avoid government shutdown

    September 20, 2025

    Trending

    Majority of men of color support protecting abortion access: Poll

    Majority of men of color support protecting abortion access: Poll

    May 30, 2024
    Small study hints anti-amyloid therapy may keep Alzheimer’s symptoms at bay in certain patients

    Small study hints anti-amyloid therapy may keep Alzheimer’s symptoms at bay in certain patients

    March 22, 2025
    UnitedHealthcare CEO shooting suspect wrote that he acted alone: Report

    UnitedHealthcare CEO shooting suspect wrote that he acted alone: Report

    December 10, 2024
    Forced labor designation for Cuban doctors highlights rift over sanctions

    Forced labor designation for Cuban doctors highlights rift over sanctions

    June 26, 2024

    Recent News

    Trump administration halts government hunger report

    Trump administration halts government hunger report

    September 22, 2025
    Former acting CDC director says he ‘can’t look to’ center for trusted info 

    Former acting CDC director says he ‘can’t look to’ center for trusted info 

    September 21, 2025

    Popular News

    • Trump administration halts government hunger report
    • Former acting CDC director says he ‘can’t look to’ center for trusted info 

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.